Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100452372 | 10045237 | 2 | F | 20140214 | 20160802 | 20140328 | 20160810 | EXP | FR-ASTRAZENECA-2014SE21413 | ASTRAZENECA | 31710.00 | DY | M | Y | 0.00000 | 20160810 | MD | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100452372 | 10045237 | 1 | PS | INEXIUM | ESOMEPRAZOLE | 1 | Oral | LONG LASTING TREATMENTS | 21153 | ||||||||||
| 100452372 | 10045237 | 2 | SS | KARDEGIC | ASPIRIN LYSINE | 1 | Oral | LONG LASTING TREATMENTS | 0 | ||||||||||
| 100452372 | 10045237 | 3 | SS | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | Oral | LONG LASTING TREATMENTS | 0 | ||||||||||
| 100452372 | 10045237 | 4 | C | ROCEPHINE | CEFTRIAXONE SODIUM | 1 | Intravenous (not otherwise specified) | LONG LASTING TREATMENTS | 0 | ||||||||||
| 100452372 | 10045237 | 5 | C | RULID | ROXITHROMYCIN | 1 | Intravenous (not otherwise specified) | LONG LASTING TREATMENTS | 0 | ||||||||||
| 100452372 | 10045237 | 6 | C | LAROXYL | AMITRIPTYLINE | 1 | LONG LASTING TREATMENTS | 0 | |||||||||||
| 100452372 | 10045237 | 7 | C | BISOPROLOL | BISOPROLOL | 1 | LONG LASTING TREATMENTS | 0 | |||||||||||
| 100452372 | 10045237 | 8 | C | LASILIX | FUROSEMIDE | 1 | LONG LASTING TREATMENTS | 0 | |||||||||||
| 100452372 | 10045237 | 9 | C | PARACETAMOL | ACETAMINOPHEN | 1 | LONG LASTING TREATMENTS | 0 | |||||||||||
| 100452372 | 10045237 | 10 | C | NICORANDIL | NICORANDIL | 1 | LONG LASTING TREATMENTS | 0 | |||||||||||
| 100452372 | 10045237 | 11 | C | DISCOTRINE | NITROGLYCERIN | 1 | LONG LASTING TREATMENTS | 0 | TRANSDERMAL PATCH | ||||||||||
| 100452372 | 10045237 | 12 | C | CALCIPARINE | HEPARIN CALCIUM | 1 | LONG LASTING TREATMENTS | 0 | |||||||||||
| 100452372 | 10045237 | 13 | C | AUGMENTIN | AMOXICILLINCLAVULANATE POTASSIUM | 1 | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 100452372 | 10045237 | LT |
| 100452372 | 10045237 | OT |
| 100452372 | 10045237 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 100452372 | 10045237 | Bone marrow failure | |
| 100452372 | 10045237 | Bronchitis | |
| 100452372 | 10045237 | Cardiac failure | |
| 100452372 | 10045237 | Therapy cessation | |
| 100452372 | 10045237 | Thrombocytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 100452372 | 10045237 | 1 | 20140228 | 0 | ||
| 100452372 | 10045237 | 2 | 20140225 | 0 | ||
| 100452372 | 10045237 | 3 | 20140225 | 0 | ||
| 100452372 | 10045237 | 4 | 20140220 | 20140224 | 0 | |
| 100452372 | 10045237 | 5 | 20140220 | 20140224 | 0 | |
| 100452372 | 10045237 | 12 | 20140214 | 20140221 | 0 | |
| 100452372 | 10045237 | 13 | 20140215 | 20140217 | 0 |